Beam Therapeutics Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Beam Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Beam Therapeutics Inc. Depreciation for the quarter ending June 30, 2024 was $5.58M, a 15.8% increase year-over-year.
  • Beam Therapeutics Inc. Depreciation for the twelve months ending June 30, 2024 was $21.6M, a 27.7% increase year-over-year.
  • Beam Therapeutics Inc. annual Depreciation for 2023 was $20M, a 42% increase from 2022.
  • Beam Therapeutics Inc. annual Depreciation for 2022 was $14.1M, a 95.8% increase from 2021.
  • Beam Therapeutics Inc. annual Depreciation for 2021 was $7.2M, a 52.1% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20M +$5.92M +42% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $14.1M +$6.9M +95.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $7.2M +$2.47M +52.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $4.74M +$1.23M +35.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.5M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.